Role of follistatin in promoting adipogenesis in women.

John Flanagan 1, 2 Kristina Linder 2 Niklas Mejhert 2 Elisabeth Dungner 2 Kerstin Wahlen 2 Pauline Decaunes 3 Mikael Rydén 2 Peyman Björklund 4 Stefan Arver 1, 2 Shalender Bhasin 5, 6 Anne Bouloumie 3 Peter Arner 2 Ingrid Dahlman 2, *
* Auteur correspondant
1 Andrology Center
2 Department of medicine [Stockholm]
3 I2MR - Institut de médecine moléculaire de Rangueil
4 Department of Surgical Sciences
5 Section of Endocrinology, Diabetes, and Nutrition
6 Yale Endocrine Neoplasia Laboratory
Abstract : CONTEXT: Follistatin is a glycoprotein that binds and neutralizes biological activities of TGFbeta superfamily members including activin and myostatin. We previously identified by expression profiling that follistatin levels in white adipose tissue (WAT) were regulated by obesity. OBJECTIVE: The objective of the study was to elucidate the role of follistatin in human WAT and obesity. DESIGN: We measured secreted follistatin protein from WAT biopsies and fat cells in vitro. We also quantified follistatin mRNA expression in sc and visceral WAT and in WAT-fractionated cells and related it to obesity status, body region, and cellular origin. We investigated the effects of follistatin on adipocyte differentiation of progenitor cells in vitro. PARTICIPANTS: Women (n = 66) with a wide variation in body mass index were recruited by advertisement and from a clinic for weight-reduction therapy. RESULTS: WAT secreted follistatin in vitro. Follistatin mRNA levels in sc but not visceral WAT were decreased in obesity and restored to nonobese levels after weight reduction. Follistatin mRNA levels were high in the stroma-vascular fraction of WAT and low in adipocytes. Recombinant follistatin treatment promoted adipogenic differentiation of progenitor cells and neutralized the inhibitory action of myostatin on differentiation in vitro. Moreover, activin and myostatin signaling receptors were detected in WAT and adipocytes. CONCLUSION: Follistatin is a new adipokine important for adipogenesis. Down-regulated WAT expression of follistatin in obesity may counteract adiposity but could, by inhibiting adipogenesis, contribute to hypertrophic obesity (large fat cells) and insulin resistance.
Type de document :
Article dans une revue
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2009, 94 (8), pp.3003-9. 〈10.1210/jc.2008-2005〉
Liste complète des métadonnées

Littérature citée [34 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00410107
Contributeur : Marie Francoise Simon <>
Soumis le : lundi 8 août 2011 - 13:28:33
Dernière modification le : jeudi 13 septembre 2018 - 10:26:05
Document(s) archivé(s) le : mercredi 9 novembre 2011 - 02:20:36

Fichier

3003.full.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

UNIV-TLSE3

Citation

John Flanagan, Kristina Linder, Niklas Mejhert, Elisabeth Dungner, Kerstin Wahlen, et al.. Role of follistatin in promoting adipogenesis in women.. Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2009, 94 (8), pp.3003-9. 〈10.1210/jc.2008-2005〉. 〈inserm-00410107〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

319

Téléchargements de fichiers

289

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD